| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |